Pharmacovigilance (PV) software comprises drug safety management software solution that enables to create, classify, review, submit, and maintain pharmacovigilance data and adverse event reports. This PV software is used by pharma and biotech companies, contract research organizations (CROs), business process outsourcing firms (BPOs), and other pharmacovigilance service providers.
The global pharmacovigilance software market is poised to grow at a CAGR of 6.5% during 2022-2028, and is expected to reach a value of $154.1 Million in 2019.
Factors such as rising incidence rates of adverse drug reactions (ADRs) and increasing adoption of pharmacovigilance software by outsourcing companies are driving the growth of the global drug safety software market. In addition; government regulatory bodies (such as the U.S. FDA and EMEA) have intensified safety regulations for prior and post commercialization of drugs, which has increased pressure on the pharmaceutical and biotechnology companies to manufacture safe drugs and evaluate their results post sales. Thus, growing complexity related to drug safety regulations is expected to drive the growth of the market during the forecast period.
North America is expected to account for the largest share of the drug safety software market, followed by Europe, in 2014. However, Asian and Latin American countries represent high growth markets, owing to a rise in research outsourcing by pharmaceutical giants and growing public and private investments in pharmaceutical R&D in these emerging nations. Some of the key players in the global market include ArisGlobal (U.S.), Ennov Solutions Inc. (U.S.), EXTEDO GmbH (U.S.), Online Business Applications, Inc. (U.S.), Oracle Corporation (U.S.), Sarjen Systems Pvt. Ltd (India), Sparta Systems, Inc. (U.S.), and United BioSource Corporation (U.S.), among others.
The global Pharmacovigilance and Drug Safety Software market is expected to rise with an impressive CAGR and generate the highest revenue by 2027. Zion Market Research in its latest report published this information. The report is titled Pharmacovigilance and Drug Safety Software Market . The report discusses research objectives, research scope, methodology, timeline and challenges during the entire forecast period. It also offers an exclusive insight into various details such as revenues, market share, strategies, growth rate, product & their pricing by region/country for all major companies.
The Report Lists the Key Companies in the Pharmacovigilance and Drug Safety Software Market:
Oracle Corporation, ArisGlobal LLC, AB Cube, Max Delivery, Relsys, Sparta Systems, Inc., United BioSource Corporation, EXTEDO GmbH
The report provides a 360-degree overview of the market, listing various factors restricting, propelling, and obstructing the market in the forecast duration. The report also provides additional information such as interesting insights, key industry developments, detailed segmentation of the market, list of prominent players operating in the market, and other Pharmacovigilance and Drug Safety Software market trends. The report is available for sale on the company website.
Further, the report acknowledges that in these growing and promptly enhancing market circumstances, the most recent advertising and marketing details are very important to determine the performance in the forecast period and make essential choices for profitability and growth of the Pharmacovigilance and Drug Safety Software. In addition, the report encompasses an array of factors that impact the growth of the Pharmacovigilance and Drug Safety Software in the forecast period. Further, this specific analysis also determines the impact on the individual segments of the market.
Product Types: On-premise Delivery ,On-demand/ Cloud-based (SaaS) Delivery
On the Basis of Application: Pharma & Biotech Companies, Contract Research Organizations (CROS), Business Process Outsourcing (BPO
FREE : Request Sample is Available @ https://www.zionmarketresearch.com/sample/pharmacovigilance-drug-safety-software-market
Regional Analysis for Pharmacovigilance and Drug Safety Software Market :
- North America (the USA and Canada)
- Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)
- Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)
- Latin America (Brazil, Mexico and Rest of Latin America)
- Middle East & Africa (South Africa, GCC and Rest of the Middle East & Africa)
Major Table of Contents for Pharmacovigilance and Drug Safety Software Market :
4.Key Pharmacovigilance and Drug Safety Software Market Insights
5.Global Market Analysis, Insights and Forecast, 2015-2027
6.North America Market Analysis, Insights and Forecast, 2015-2027
7.Europe Market Analysis, Insights and Forecast, 2015-2027
8.Asia Pacific Market Analysis, Insights and Forecast, 2015-2027
9.The Middle East and Africa Market Analysis, Insights and Forecast, 2015-2027
10.Latin America Market Analysis, Insights and Forecast, 2015-2027
12.Global Pharmacovigilance and Drug Safety Software Market Revenue Share Analysis, By Key Players, 2021
Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe or Asia.